C

Concert Pharmaceuticals Inc
F:73C

Watchlist Manager
Concert Pharmaceuticals Inc
F:73C
Watchlist
Price: 7.818 EUR Market Closed
Market Cap: 374.8m EUR

Net Margin
Concert Pharmaceuticals Inc

-390 564.3%
Current
-33 781%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-390 564.3%
=
Net Income
-164m
/
Revenue
42k

Net Margin Across Competitors

No Stocks Found

Concert Pharmaceuticals Inc
Glance View

Market Cap
374.8m EUR
Industry
Biotechnology

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. The company is headquartered in Lexington, Massachusetts and currently employs 64 full-time employees. The company went IPO on 2014-02-13. The firm is focused on developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 (JAK 1/2) inhibitor that discovered through deuterated chemical entity Platform (DCE platform). The firm is evaluating CTP-543 in a Phase III clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. Through DCE Platform, the Company has discovered and developed novel drugs designed to have properties, including enhanced clinical safety, tolerability or efficacy based on compounds. DCE technology has range of potential across numerous therapeutic areas, including for chronic diseases for which medicines are continually used by patients. The firm is assessing earlier-stage pipeline candidates as potential development candidates, including a once-daily, modified release formulation of CTP-543.

73C Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-390 564.3%
=
Net Income
-164m
/
Revenue
42k
What is the Net Margin of Concert Pharmaceuticals Inc?

Based on Concert Pharmaceuticals Inc's most recent financial statements, the company has Net Margin of -390 564.3%.

Back to Top